Diruthenium Compound Effectively Inhibits Amyloid-β Aggregation and Reduces Cytotoxicity: Potential Neurodrugs for Alzheimer’s Disease Management

https://pubmed.ncbi.nlm.nih.gov/38117944

A diruthenium compound with formamidinate ligands effectively inhibits Amyloid-β aggregation and reduces its cytotoxicity, highlighting its potential as a neurodrugs for managing Alzheimer’s disease.